Scientists Propose MMCK Syndrome to Put the Liver at the Heart of Cardiometabolic Risk
A new review proposes the MMCK syndrome, an operational extension of the CKM framework that integrates MASLD liver fibrosis scoring ...
Tag: GLP-1 receptor agonists
Combining SGLT2 inhibitors and GLP-1 drugs in heart failure: promising but unproven
A new review finds that combining SGLT2 inhibitors with GLP-1 receptor agonists in heart failure is mechanistically plausible and generally ...
Tirzepatide Tied to Pancreatitis-Free Year in Severe Diabetes Case
A published case report describes a woman with type 2 diabetes and recurrent hypertriglyceridemia-mediated pancreatitis whose triglycerides, blood sugar and ...
GLP-1 Receptor Agonists Show Kidney Protection in Lupus-Prone Mice
Liraglutide reduced proteinuria and kidney injury in lupus-prone mice through anti-inflammatory, antioxidant, and ferroptosis-related mechanisms, with cAMP signaling implicated.
GLP-1 Diabetes Drugs Linked to Greater Thyroid Hormone Sensitivity in Large Study
A cross-sectional study of 7,697 adults with type 2 diabetes found GLP-1 receptor agonist use was associated with lower TFQI ...
AI Reads Chest X-rays to Spot Early Heart Dysfunction in Obesity and Diabetes
A small Mayo Clinic exploratory study suggests AI-enabled chest x-ray staging can detect subclinical diastolic dysfunction in obesity and diabetes ...
GLP-1 Drug Use Linked to Better Survival in Diabetic Flesh-Eating Infections
A retrospective matched study of 16,792 patients with type 2 diabetes found GLP-1 receptor agonist use before necrotizing soft tissue ...
Largest Subject-Level Trial Analysis Finds No Raised Suicide Risk With GLP-1 Drugs
A subject-level analysis of 91 placebo-controlled trials covering nearly 108,000 participants found no increased risk of suicidal ideation or behavior ...
GLP-1 drugs may not help every form of heart failure, researchers warn
A new commentary argues that GLP-1 receptor agonists' heart failure hospitalization benefit may not apply across all heart failure phenotypes.
Oral GLP-1 therapies reshape obesity treatment, review finds
A new review in Cardiovascular Diabetology describes how FDA-approved oral GLP-1 receptor agonists such as semaglutide and orforglipron are expanding ...
-
Mothers who receive childcare support from maternal grandparents show more parental warmth, finds NTU Singapore study
-
University of Seville Breaks 120-Year-Old Mystery, Revises a Key Einstein Concept
-
Bee body mass, pathogens and local climate influence heat tolerance
-
Researchers record first-ever images and data of a shark experiencing a boat strike
-
Groundbreaking Clinical Trial Reveals Lubiprostone Enhances Kidney Function
Embark on a thrilling journey of discovery with Scienmag.com—your ultimate source for cutting-edge breakthroughs. Immerse yourself in a world where curiosity knows no limits and tomorrow’s possibilities become today’s reality!